Use of VAP-1 inhibitors for treating fibrotic conditions

Details for Australian Patent Application No. 2010294123 (hide)

Owner Biotie Therapies Corp. The University of Birmingham

Inventors Weston, Christopher; Claridge, Lee Charles; Adams, David; Smith, David; Westerlund, Nina; Pihlavisto, Marjo; Osterman, Thua

Agent Shelston IP

Pub. Number AU-A-2010294123

PCT Pub. Number WO2011/029996

Priority 61/240,402 08.09.09 US; 61/323,032 12.04.10 US

Filing date 7 September 2010

Wipo publication date 17 March 2011

International Classifications

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

A61K 31/00 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

Event Publications

12 April 2012 PCT application entered the National Phase

  PCT publication WO2011/029996 Priority application(s): WO2011/029996

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010294140-Intracorporeal device for moving tissue

2010294119-Rock drilling unit, feed beam, and method for damping vibration